跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
艾而赞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Laronidase concentrated solution for infusion
Approved
生物制品
Laronidase concentrated solution for infusion
Sanofi B.V.
🇨🇳 National Medical Products Administration
Approval Date
Jun 2, 2020
Approval ID
7yn0cqhP6vK
Company
Sanofi B.V.
Type
生物制品
Approval Details
Approval Id
7yn0cqhP6vK
Approval Number
S20200010
Generic Name
注射用拉罗尼酶浓溶液
Generic Name En
Laronidase concentrated solution for infusion
Trade Name
艾而赞
Drug Type
生物制品
Dosage Form
注射剂
Strength
500U(5ml)/瓶
Reg Date
2020-06-02
Expired Date
2025-06-01
Company Name
Sanofi B.V.
Company Address
Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Production Company Address
Eisenbahnstrasse 2-4, 88085 Langenargen, Germany
Company Detail Path
/organization/sanofi-b-v
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 2, 2020
Approval ID
7yn0cqhP6vK
Type
生物制品
Back to NMPA Approvals